Search research articles
Contact Us
Filters
Showing results (81-90 of 231) with videos related to
Page
of 24
Sort By:
British Journal of Haematology
|
July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
Anjali S Advani, Shannon McDonough, Edward Copelan, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Leukemia
|
June 3, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203
Michelle Y Zhang, Megan Othus, Kerry McMillen, et al.
Cancer Medicine
|
October 11, 2017
High frequency of brain metastases after adjuvant therapy for high-risk melanoma
Wolfram E Samlowski, James Moon, Merle Witter, et al.
Clinical Trials (London, England)
|
January 16, 2025
Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials
Anna Moseley, Michael LeBlanc, Boris Freidlin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 26, 2019
Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia
Evandro D Bezerra, Megan Othus, Carole Shawn, et al.
Haematologica
|
March 26, 2016
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI
Megan Othus, Wim van Putten, Bob Lowenberg, et al.
Haematologica
|
August 4, 2022
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
Corentin Orvain, Jacob A Wilson, Min Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
Roland B Walter, Megan Othus, Gautam Borthakur, et al.
Cancer Medicine
|
July 25, 2020
Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML
Mohamed L Sorror, Shirali Agarwal, Megan Othus, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 231) with videos related to
Sort By:
Page
of 24
British Journal of Haematology
|
July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
Anjali S Advani, Shannon McDonough, Edward Copelan, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Leukemia
|
June 3, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203
Michelle Y Zhang, Megan Othus, Kerry McMillen, et al.
Cancer Medicine
|
October 11, 2017
High frequency of brain metastases after adjuvant therapy for high-risk melanoma
Wolfram E Samlowski, James Moon, Merle Witter, et al.
Clinical Trials (London, England)
|
January 16, 2025
Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials
Anna Moseley, Michael LeBlanc, Boris Freidlin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 26, 2019
Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia
Evandro D Bezerra, Megan Othus, Carole Shawn, et al.
Haematologica
|
March 26, 2016
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI
Megan Othus, Wim van Putten, Bob Lowenberg, et al.
Haematologica
|
August 4, 2022
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
Corentin Orvain, Jacob A Wilson, Min Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
Roland B Walter, Megan Othus, Gautam Borthakur, et al.
Cancer Medicine
|
July 25, 2020
Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML
Mohamed L Sorror, Shirali Agarwal, Megan Othus, et al.
Page
of 24